Effect of ouabain on myocardial remodeling in rats

Ren,Yanping; Zhang,Mingjuan; Zhang,Ting; Huang,Ruowen

doi:10.3892/etm.2013.1098

Effect of ouabain on myocardial remodeling in rats

Authors:
- Yanping Ren
- Mingjuan Zhang
- Ting Zhang
- Ruowen Huang
View Affiliations

Affiliations: Geriatric-Cardiovascular Department, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Cardiovascular Department, The Second Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710003, P.R. China
Published online on: May 2, 2013 https://doi.org/10.3892/etm.2013.1098
Pages: 65-70

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the effect of ouabain (EO) on myocardial remodeling. Twenty-two adult male Sprague-Dawley rats were randomly divided into two groups: the rats in the EO group (n=12) were intraperitoneally injected with EO daily and those in the control group (n=10) were injected with physiological saline daily. After 8 weeks the rats were sacrificed. The ultrastructural changes in the myocardium were observed. The expression levels of voltage‑gated potassium channel 4.2 (KV4.2) were detected by real-time quantitative reverse transcription-polymerase chain reaction. The effects of EO on the myocardial action potential and transient potassium efflux (Ito) were measured by patch clamping. The systolic blood pressure (SBP) of 10 of the 12 rats in the EO group, designated as the EO-sensitive (OS) rats, began to increase from the fifth week of treatment and was significantly higher compared with that of the control group 6 weeks later (P<0.01). The remaining 2 rats in the EO group that presented no increase in SBP following 8 weeks of treatment (P>0.05) were designated as EO-resistant (OR) rats. Pathological ultrastructural changes were significant in the apical mid-myocardium of the OS rats. No significant differences in KV4.2 expression were observed among the OS, OR and control rats. The patch clamp results revealed that EO prolongs the action potential duration, reduces Ito and triggers the electrical remodeling of the myocardium. EO induces a blood pressure increase and triggers structural and electrical remodeling.

View Figures

View References

1.	Boulanger BR, Lilly MP, Hamlyn JM, Laredo JM, Shurtleff D and Gann DS: Ouabain is secreted by the adrenal gland in awake dogs. Am J Physiol. 264:E413–E419. 1993.PubMed/NCBI
2.	Hamlyn JM, Blaustein MP, Bova S, et al: Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA. 88:6259–6263. 1991. View Article : Google Scholar : PubMed/NCBI
3.	Manunta P, Messaggio E, Ballabeni C, et al: Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Hypertension. 38:198–203. 2001. View Article : Google Scholar : PubMed/NCBI
4.	Manunta P, Ferrandi M, Bianchi G and Hamlyn JM: Endogenous ouabain in cardiovascular function and disease. J Hypertens. 27:9–18. 2009. View Article : Google Scholar
5.	Manunta P, Stella P, Rivera R, et al: Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension. 34:450–456. 1999.PubMed/NCBI
6.	Pierdomenico SD, Bucci A, Manunta P, et al: Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. Am J Hypertens. 14:44–50. 2001. View Article : Google Scholar : PubMed/NCBI
7.	Balzan S, Nicolini G, Iervasi A, Dicecco P and Fommei E: Endogenous ouabain and acute salt loading in low-renin hypertension. Am J Hypertens. 18:906–909. 2005. View Article : Google Scholar : PubMed/NCBI
8.	Bagrov AY, Shapiro JI and Fedorova OV: Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev. 61:9–38. 2009. View Article : Google Scholar : PubMed/NCBI
9.	Huang BS and Leenen FH: Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension. 34:107–112. 1999. View Article : Google Scholar : PubMed/NCBI
10.	Di Filippo C, Filippelli A, Rinaldi B, et al: Chronic peripheral ouabain treatment affects the brain endothelin system of rats. J Hypertens. 21:747–753. 2003.PubMed/NCBI
11.	Xavier FE, Yogi A, Callera GE, et al: Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain. Br J Pharmocol. 143:794–802. 2004. View Article : Google Scholar : PubMed/NCBI
12.	Ren YP, Huang RW and Lü ZR: Ouabain at pathological concentration might induce damage in human vascular endothelial cells. Acta Pharmacol Sin. 27:165–172. 2006. View Article : Google Scholar : PubMed/NCBI
13.	Huang BS, Huang X, Harmsen E and Leenen FH: Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension. 23:1087–1090. 1994. View Article : Google Scholar : PubMed/NCBI
14.	Kimura K, Manunta P, Hamilton BP and Hamlyn JM: Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat. Hypertens Res. 23:S67–S76. 2000. View Article : Google Scholar : PubMed/NCBI
15.	Ferrari P: Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension. Biochim Biophys Acta. 1802:1254–1258. 2010. View Article : Google Scholar : PubMed/NCBI
16.	Ferrari P, Ferrandi M, Valentini G, Manunta P and Bianchi G: Targeting ouabain- and adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach. Med Hypotheses. 68:1307–1314. 2007. View Article : Google Scholar : PubMed/NCBI
17.	Abreu GR, Futuro Neto HA, Cabral AM and Vasquez EC: Ouabain produces diverse excitatory effects on afferent baro-receptor nerve activity in SHR and WKY animals. Clin Exp Hypertens. 20:85–94. 1998. View Article : Google Scholar : PubMed/NCBI
18.	Manunta P, Hamilton J, Rogowski AC, Hamilton BP and Hamlyn JM: Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertens Res. 23:S77–S85. 2000. View Article : Google Scholar : PubMed/NCBI
19.	Yuan CM, Manunta P, Hamlyn JM, et al: Long-term ouabain administration produces hypertension in rats. Hypertension. 22:178–187. 1993. View Article : Google Scholar : PubMed/NCBI
20.	Abramowitz J, Dai C, Hirschi KK, et al: Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and rat vascular smooth muscle cell line, A7r5. Circulation. 108:3048–3053. 2003. View Article : Google Scholar : PubMed/NCBI
21.	Aydemir-Koksoy A, Abramowitz J and Allen JC: Ouabain-induced signaling and vascular smooth muscle cell proliferation. J Biol Chem. 276:46605–46611. 2001. View Article : Google Scholar : PubMed/NCBI
22.	Huang BS and Leenen FH: The brain renin-angiotensin-aldosterone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction. Curr Heart Fail Rep. 6:81–88. 2009. View Article : Google Scholar
23.	Rossoni LV, Salaices M, Miguel M, et al: Ouabain induced hyper-tension is accompanied by increases in endothelial vasodilator factors. Am J Physiol Heart Circ Physiol. 283:H2110–H2118. 2002. View Article : Google Scholar : PubMed/NCBI
24.	Aras-López R, Blanco-Rivero J, Hernanz R, et al: Chronic ouabain treatment increases the contribution of nitric oxide to endothelium-dependent relaxation. J Physiol Biochem. 64:115–125. 2008.PubMed/NCBI
25.	Jiang X, Ren YP and Lv ZR: Ouabain induces cardiac remodeling in rats independent of blood pressure. Acta Pharmacol Sin. 28:344–352. 2007. View Article : Google Scholar : PubMed/NCBI
26.	Volk T, Nguyen TH, Schultz JH, Faulhaber J and Ehmke H: Regional alterations of repolarizing K⁺ currents among the left ventricular free wall of rats with ascending aortic stenosis. J Physiol. 530:443–455. 2001.PubMed/NCBI
27.	Singarayar S, Singleton C, Tie H, et al: Effects of components of ischemia on the Kv4.3 current stably expressed in Chinese hamster ovary cells. J Mol Cell Cardiol. 34:197–207. 2002. View Article : Google Scholar : PubMed/NCBI
28.	Lukas A and Antzelevitch C: Differences in the electro-physiological response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current. Circulation. 88:2903–2915. 1993. View Article : Google Scholar : PubMed/NCBI
29.	Verkerk AO, Wilders R, Coronel R, Ravesloot JH and Verheijck EE: Ionic remodeling of sinoatrial node cells by heart failure. Circulation. 108:760–766. 2003. View Article : Google Scholar : PubMed/NCBI
30.	Matsumoto S, Yoshida S, Ikeda M, et al: Effects of acetazolamide on transient K⁺ currents and action potentials in nodose ganglion neurons of adult rats. CNS Neurosci Ther. 17:66–79. 2011.
31.	Matsumoto S, Kitagawa J and Takeda M: The effects of ouabain on resting membrane potential and hyperpolarization-activated current in neonatal rat nodose ganglion neurons. Neurosci Lett. 439:241–244. 2008. View Article : Google Scholar : PubMed/NCBI